KRT7 and esophageal squamous cell carcinoma: In the previous report, esophageal SCC consistently expressed CK5/6 (in 98% of all cases) and p63 (100%) with strong reactivity, partially expressed CK7 (34%) and CDX2 (27%), but most of CK7 and CDX2 expression demonstrated weak reactivity [8].